Financhill
Buy
60

KROS Quote, Financials, Valuation and Earnings

Last price:
$21.28
Seasonality move :
6.31%
Day range:
$20.26 - $21.93
52-week range:
$9.12 - $72.37
Dividend yield:
0%
P/E ratio:
14.06x
P/S ratio:
3.57x
P/B ratio:
0.94x
Volume:
1.1M
Avg. volume:
1.2M
1-year change:
-66.43%
Market cap:
$660.8M
Revenue:
$3.6M
EPS (TTM):
$1.54

Earnings Data

Next earnings date for KROS
Feb 25
2026
Most recent earnings per share
-$0.18
Beat by $0.74
(Nov 5/2025)
Consensus Estimate
-$0.92
(Nov 5/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

KROS Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/25/2026 Q4 $3.7M -- -- -$0.44 --
11/05/2025 Q3 $4.2M $14.3M -$0.18 -$0.92 $0.74
08/07/2025 Q2 $4.2M $18.2M -$0.76 -$1.13 $0.37
05/07/2025 Q1 $56.6M $211.2M $3.62 $0.01 $3.61
02/26/2025 Q4 $37.3M $3M -$1.14 -$0.43 -$0.71
11/06/2024 Q3 -- $388K -$1.41 -$1.28 -$0.13
08/07/2024 Q2 -- $37K -$1.25 -$1.25 -$0.00
05/08/2024 Q1 -- $83K -$1.21 -$1.33 $0.13
02/28/2024 Q4 -- $143K -$1.34 -$1.39 $0.06
11/06/2023 Q3 -- $8K -$1.33 -$1.35 $0.02
08/07/2023 Q2 -- -- -$1.27 -- --
05/04/2023 Q1 -- -- -$1.26 -- --
03/03/2023 Q4 -- -- -$1.09 -- --
11/03/2022 Q3 -- -- -$0.92 -- --
08/04/2022 Q2 -- -- -$1.13 -- --
05/05/2022 Q1 -- -- -$1.01 -- --
03/09/2022 Q4 -- $20M -$0.30 -- --
11/04/2021 Q3 -- -- -$0.87 -- --
08/05/2021 Q2 -- $100K -$0.67 -- --
05/06/2021 Q1 -- -- -$0.68 -- --
03/25/2021 Q4 -- -- -$0.49 -- --
11/10/2020 Q3 -- -- -$0.60 -- --
08/13/2020 Q2 -- -- -$0.62 -- --
05/22/2020 Q1 -- -- -$0.63 -- --
12/31/2019 Q4 -- $2.5M -$0.18 -- --
09/30/2019 Q3 -- $2.5M -$0.20 -- --
06/30/2019 Q2 -- $2.5M -$1.44 -- --
03/31/2019 Q1 -- $2.5M -$0.18 -- --

Keros Therapeutics, Inc. Earnings Questions

  • How Much did Keros Therapeutics, Inc. Generate in Revenue Last Quarter?

    Keros Therapeutics, Inc. reported $14.3M worth of top line sales in its most recent quarter.

  • Did Keros Therapeutics, Inc. Beat Earnings Last Quarter?

    Keros Therapeutics, Inc. announced earnings per share of -$0.18 which represents a beat of analyst forecast a -$0.92 per share.

  • Is Keros Therapeutics, Inc. Profitable?

    Keros Therapeutics, Inc. reported $13.9M that represents $0.34 per share over the last quarter.

  • What is the Analyst Consensus for Keros Therapeutics, Inc. EPS Next Year?

    Keros Therapeutics, Inc.'s earnings are forecast to decrease from -$5.00 per share to -$4.12 per share next year representing a decrease of -97.1%.

  • When is Keros Therapeutics, Inc.'s Earnings Date?

    Keros Therapeutics, Inc.'s next earnings date is February 25, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 59.64% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.18% over the past day.

Sell
13
PSN alert for Dec 8

Parsons Corp. [PSN] is down 5.19% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock